Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Clinical trial NCT07290270 · RECRUITING

Trial details

NCT number: NCT07290270
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Prostate Cancer

Start date: 2026-02-04
Primary completion: 2029-08-31
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.